These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 16635306

  • 1. [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Chen Y, Wang ZM, Ren ZG, Le F, Zhang BH, Xia JL, Ye SL, Tang ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):299-300. PubMed ID: 16635306
    [No Abstract] [Full Text] [Related]

  • 2. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N.
    J Hepatobiliary Pancreat Surg; 2006 Apr; 13(6):537-42. PubMed ID: 17139428
    [Abstract] [Full Text] [Related]

  • 3. [In vivo proton magnetic resonance spectroscopy of hepatocellular carcinoma and cholangiocarcinoma].
    Dong AS, Tian JM, Lu JP, Zuo CJ, Wang L, Wang J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):151-4. PubMed ID: 19507591
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G, Makuuchi M, Ferrero A, Takayama T, Hui AM, Abe H, Inoue K, Nakahara K.
    Hepatogastroenterology; 2002 Apr; 49(45):740-5. PubMed ID: 12063982
    [Abstract] [Full Text] [Related]

  • 5. Hepatobiliary tumours.
    Simcock R.
    Practitioner; 2001 Aug; 245(1625):668-74. PubMed ID: 11524939
    [No Abstract] [Full Text] [Related]

  • 6. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
    Li YG, Zhang N.
    Dig Liver Dis; 2009 Aug; 41(8):605-8. PubMed ID: 19168405
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
    Dong H, Cong WL, Zhu ZZ, Wang B, Xian ZH, Yu H.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M.
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [Abstract] [Full Text] [Related]

  • 9. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
    Maeda Y, Nishida M, Mori N, Tamesa T, Okada T, Tangoku A, Oka M.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():401-5. PubMed ID: 11761981
    [No Abstract] [Full Text] [Related]

  • 10. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL, Das KM, Fogt F, Burke M, Murakata LA.
    Oncol Rep; 2002 Oct; 9(6):1369-72. PubMed ID: 12375050
    [Abstract] [Full Text] [Related]

  • 11. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M, Ariizumi S, Otsubo T, Katsuragawa H, Katagiri S, Nakano M, Takasaki K.
    J Surg Oncol; 2004 Aug 01; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [Abstract] [Full Text] [Related]

  • 12. Combined hepatocellular and cholangiocellular carcinoma.
    Murakami T, Kim T, Tomoda K, Narumi Y, Sakon M, Wakasa K, Nakamura H.
    Radiat Med; 1997 Aug 01; 15(4):243-6. PubMed ID: 9311042
    [Abstract] [Full Text] [Related]

  • 13. A resected case of a small hepatocellular carcinoma developing within the bile duct.
    Yasui O, Sato T, Andoh H, Kurokawa T, Watanabe D, Sageshima M, Nanjo H.
    J Hepatobiliary Pancreat Surg; 2004 Aug 01; 11(3):193-6. PubMed ID: 15235893
    [Abstract] [Full Text] [Related]

  • 14. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec 01; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 15. [Cholangiocellular carcinoma associated with liver cirrhosis].
    Suzuki Y, Aoyagi Y, Naitoh A, Isokawa O.
    Ryoikibetsu Shokogun Shirizu; 1995 Dec 01; (7):357-9. PubMed ID: 8749494
    [No Abstract] [Full Text] [Related]

  • 16. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    Lempinen M, Isoniemi H, Mäkisalo H, Nordin A, Halme L, Arola J, Höckerstedt K, Stenman UH.
    J Hepatol; 2007 Nov 01; 47(5):677-83. PubMed ID: 17640760
    [Abstract] [Full Text] [Related]

  • 17. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ.
    Am J Gastroenterol; 2000 Jan 01; 95(1):204-7. PubMed ID: 10638584
    [Abstract] [Full Text] [Related]

  • 18. Mirizzi's syndrome with a high CA19-9 level mimicking cholangiocarcinoma.
    Lin CL, Changchien CS, Chen YS.
    Am J Gastroenterol; 1997 Dec 01; 92(12):2309-10. PubMed ID: 9399781
    [No Abstract] [Full Text] [Related]

  • 19. [Combined hepatocellular-cholangiocarcinoma].
    Jeen YM, Jin SY.
    Korean J Hepatol; 2007 Dec 01; 13(4):571-5. PubMed ID: 18159156
    [No Abstract] [Full Text] [Related]

  • 20. MR imaging of the liver. Primary malignant neoplasms in the adult.
    Buetow PC, Midkiff RB.
    Magn Reson Imaging Clin N Am; 1997 May 01; 5(2):289-318. PubMed ID: 9113676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.